IXICO (IXI) Competitors GBX 12 +0.50 (+4.35%) (As of 12:11 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlines IXI vs. OBI, HEMO, AOR, RLM, NSCI, OPTI, ONC, SNG, BVX, and CIZShould you be buying IXICO stock or one of its competitors? The main competitors of IXICO include Ondine Biomedical (OBI), Hemogenyx Pharmaceuticals (HEMO), AorTech International (AOR), Realm Therapeutics (RLM), NetScientific (NSCI), OptiBiotix Health (OPTI), Oncimmune (ONC), Synairgen (SNG), BiVictriX Therapeutics (BVX), and Cizzle Biotechnology (CIZ). These companies are all part of the "biotechnology" industry. IXICO vs. Ondine Biomedical Hemogenyx Pharmaceuticals AorTech International Realm Therapeutics NetScientific OptiBiotix Health Oncimmune Synairgen BiVictriX Therapeutics Cizzle Biotechnology IXICO (LON:IXI) and Ondine Biomedical (LON:OBI) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, profitability, risk, community ranking, valuation, earnings, analyst recommendations and media sentiment. Is IXI or OBI more profitable? Ondine Biomedical has a net margin of 0.00% compared to IXICO's net margin of -31.10%. IXICO's return on equity of -16.99% beat Ondine Biomedical's return on equity.Company Net Margins Return on Equity Return on Assets IXICO-31.10% -16.99% -10.40% Ondine Biomedical N/A -685.59%-159.71% Does the MarketBeat Community believe in IXI or OBI? IXICO received 143 more outperform votes than Ondine Biomedical when rated by MarketBeat users. However, 100.00% of users gave Ondine Biomedical an outperform vote while only 71.64% of users gave IXICO an outperform vote. CompanyUnderperformOutperformIXICOOutperform Votes14471.64% Underperform Votes5728.36% Ondine BiomedicalOutperform Votes1100.00% Underperform VotesNo Votes Does the media favor IXI or OBI? In the previous week, IXICO's average media sentiment score of 0.00 equaled Ondine Biomedical'saverage media sentiment score. Company Overall Sentiment IXICO Neutral Ondine Biomedical Neutral Which has preferable earnings & valuation, IXI or OBI? IXICO has higher revenue and earnings than Ondine Biomedical. IXICO is trading at a lower price-to-earnings ratio than Ondine Biomedical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioIXICO£6M0.97-£1.87M-£0.04-300.00Ondine Biomedical£1.63M13.61-£14.27M-£0.03-266.73 Which has more volatility & risk, IXI or OBI? IXICO has a beta of 0.86, indicating that its share price is 14% less volatile than the S&P 500. Comparatively, Ondine Biomedical has a beta of 0.1, indicating that its share price is 90% less volatile than the S&P 500. Do insiders & institutionals believe in IXI or OBI? 56.0% of IXICO shares are held by institutional investors. Comparatively, 20.6% of Ondine Biomedical shares are held by institutional investors. 30.3% of IXICO shares are held by company insiders. Comparatively, 36.7% of Ondine Biomedical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. SummaryIXICO beats Ondine Biomedical on 7 of the 13 factors compared between the two stocks. Ad Colonial MetalsTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners…Claim your FREE 2024 Gold Guide Get IXICO News Delivered to You Automatically Sign up to receive the latest news and ratings for IXI and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IXI vs. The Competition Export to ExcelMetricIXICOBiotechnology IndustryMedical SectorLON ExchangeMarket Cap£5.56M£164.71M£5.05B£1.38BDividend Yield1.27%3.25%4.97%11.73%P/E Ratio-287.50329.4797.341,551.35Price / Sales0.9314,857.981,218.42209,189.85Price / Cash2.2511.6733.5132.93Price / Book0.557.115.802.80Net Income-£1.87M-£18.52M£119.07M£152.70M7 Day Performance33.38%-0.25%-1.83%-0.54%1 Month Performance16.75%8.08%-3.64%7.07%1 Year Performance-17.86%25.99%31.62%91.74% IXICO Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IXIIXICON/AGBX 12+4.3%N/A-24.6%£5.80M£6M-300.0089Gap UpOBIOndine BiomedicalN/AGBX 8-1.5%N/A-18.4%£22.19M£1.63M-270.83N/AHEMOHemogenyx PharmaceuticalsN/AGBX 1.55+8.0%N/A-42.6%£20.77MN/A-155.0014Gap DownAORAorTech InternationalN/AGBX 123.50-2.4%N/AN/A£19.99M£539,000.00-33.383RLMRealm TherapeuticsN/AGBX 11.50flatN/A+0.0%£13.41M£501,919.00-0.66N/ANSCINetScientificN/AN/AN/A-18.2%£12.81M£1.45M-486.3626OPTIOptiBiotix HealthN/AGBX 12.12-6.8%N/A-52.3%£11.87M£1.26M-404.071Gap DownONCOncimmuneN/AGBX 15.14+0.3%N/A-33.2%£11.23M£1.21M-504.6752Positive NewsHigh Trading VolumeSNGSynairgenN/AGBX 4.92+7.2%N/A-26.6%£9.91M£79,000.00-146.6034Gap UpBVXBiVictriX TherapeuticsN/AGBX 10+17.6%N/A-9.1%£8.25MN/A-250.0017Gap UpHigh Trading VolumeCIZCizzle BiotechnologyN/AGBX 1.83+7.6%N/A-15.5%£7.25M£25,000.00-188.004Gap Up Related Companies and Tools Related Companies OBI Competitors HEMO Competitors AOR Competitors RLM Competitors NSCI Competitors OPTI Competitors ONC Competitors SNG Competitors BVX Competitors CIZ Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (LON:IXI) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IXICO plc Please log in to your account or sign up in order to add this asset to your watchlist. Share IXICO With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
